The U.S. Food and Drug Administration (FDA) approves Depo-Provera, an injectable contraceptive, despite objections from the National Women’s Health Network (NWHN), the National Black Women’s Health Project (NBWHP), and the Women’s Health Education Project (WHEP).
By this time, Depo-Provera is frequently given to Women of Color in public health clinics, often under coercion from clinicians or without adequate medical information about its side effects.